Integration of Protein Kinases MTOR and Extracellular Signal-regulated Kinase 5 in Regulating Nucleocytoplasmic Localization of NFATc4

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2008 Mar 19

PMID 18347059

Citations 29

Authors

Teddy T C Yang

Raymond Y L Yu

Anissa Agadir

Guo-Jian Gao

Roberto Campos-Gonzalez

Cathy Tournier

Chi-Wing Chow

Affiliations

Soon will be listed here.

Abstract

The target of rapamycin (TOR) signaling regulates the nucleocytoplasmic shuttling of transcription factors in yeast. Whether the mammalian counterpart of TOR (mTOR) also regulates nucleocytoplasmic shuttling is not known. Using a phospho-specific monoclonal antibody, we demonstrate that mTOR phosphorylates Ser(168,170) of endogenous NFATc4, which are conserved gate-keeping Ser residues that control NFAT subcellular distribution. The mTOR acts as a basal kinase during the resting state to maintain NFATc4 in the cytosol. Inactivation and nuclear export of NFATc4 are mediated by rephosphorylation of Ser(168,170), which can be a nuclear event. Kinetic analyses demonstrate that rephosphorylation of Ser(168,170) of endogenous NFATc4 is mediated by mTOR and, surprisingly, by extracellular signal-regulated kinase 5 (ERK5) mitogen-activated protein kinase as well. Ablation of ERK5 in the Erk5(-/-) cells ascertains defects in NFATc4 rephosphorylation and nucleocytoplasmic shuttling. In addition, phosphorylation of NFATc4 by ERK5 primes subsequent phosphorylation mediated by CK1alpha. These results demonstrate that distinct protein kinases are integrated to phosphorylate the gate-keeping residues Ser(168,170) of NFATc4, to regulate subcellular distribution. These data also expand the repertoire of physiological substrates of mTOR and ERK5.

Citing Articles

AKAP6 controls NFATc4 activity for BDNF-mediated neuroprotection.

Mackiewicz J, Tomczak J, Lisek M, Guo F, Boczek T Mol Brain. 2024; 17(1):85.

PMID: 39578909 PMC: 11585144. DOI: 10.1186/s13041-024-01157-8.

How does NFAT3 regulate the occurrence of cardiac hypertrophy?.

Hui W, Wenhua S, Shuojie Z, Lulin W, Panpan Z, Tongtong Z Int J Cardiol Heart Vasc. 2023; 48:101271.

PMID: 37753338 PMC: 10518445. DOI: 10.1016/j.ijcha.2023.101271.

Recent knowledge of NFATc4 in oncogenesis and cancer prognosis.

Zhong Q, Zha S, Lau A, Xu Y Cancer Cell Int. 2022; 22(1):212.

PMID: 35698138 PMC: 9190084. DOI: 10.1186/s12935-022-02619-6.

Epigenetic regulation of autophagy: A key modification in cancer cells and cancer stem cells.

Mandhair H, Novak U, Radpour R World J Stem Cells. 2021; 13(6):542-567.

PMID: 34249227 PMC: 8246247. DOI: 10.4252/wjsc.v13.i6.542.

Phloretin Alleviates Arsenic Trioxide-Induced Apoptosis of H9c2 Cardiomyoblasts via Downregulation in Ca/Calcineurin/NFATc Pathway and Inflammatory Cytokine Release.

Vadavanath Prabhakaran V, Kozhiparambil Gopalan R Cardiovasc Toxicol. 2021; 21(8):642-654.

PMID: 34037972 DOI: 10.1007/s12012-021-09655-0.

References

Hogan P, Chen L, Nardone J, Rao A . Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003; 17(18):2205-32. DOI: 10.1101/gad.1102703. View

Mody N, Leitch J, Armstrong C, DIXON J, Cohen P . Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett. 2001; 502(1-2):21-4. DOI: 10.1016/s0014-5793(01)02651-5. View

Okamura H, Garcia-Rodriguez C, Martinson H, Qin J, Virshup D, Rao A . A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1. Mol Cell Biol. 2004; 24(10):4184-95. PMC: 400483. DOI: 10.1128/MCB.24.10.4184-4195.2004. View

Sohn S, Sarvis B, Cado D, Winoto A . ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression. J Biol Chem. 2002; 277(45):43344-51. DOI: 10.1074/jbc.M207573200. View

Gwack Y, Sharma S, Nardone J, Tanasa B, Iuga A, Srikanth S . A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature. 2006; 441(7093):646-50. DOI: 10.1038/nature04631. View

Wang X, Finegan K, Robinson A, Knowles L, Khosravi-Far R, Hinchliffe K . Activation of extracellular signal-regulated protein kinase 5 downregulates FasL upon osmotic stress. Cell Death Differ. 2006; 13(12):2099-108. DOI: 10.1038/sj.cdd.4401969. View

Li H, Tsang C, Watkins M, Bertram P, Zheng X . Nutrient regulates Tor1 nuclear localization and association with rDNA promoter. Nature. 2006; 442(7106):1058-61. DOI: 10.1038/nature05020. View

Easton J, Houghton P . mTOR and cancer therapy. Oncogene. 2006; 25(48):6436-46. DOI: 10.1038/sj.onc.1209886. View

Kondoh K, Terasawa K, Morimoto H, Nishida E . Regulation of nuclear translocation of extracellular signal-regulated kinase 5 by active nuclear import and export mechanisms. Mol Cell Biol. 2006; 26(5):1679-90. PMC: 1430242. DOI: 10.1128/MCB.26.5.1679-1690.2006. View

10.

Wang X, Tournier C . Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal. 2005; 18(6):753-60. DOI: 10.1016/j.cellsig.2005.11.003. View

11.

Yan L, Carr J, Ashby P, Murry-Tait V, Thompson C, Arthur J . Knockout of ERK5 causes multiple defects in placental and embryonic development. BMC Dev Biol. 2003; 3:11. PMC: 324396. DOI: 10.1186/1471-213X-3-11. View

12.

Tanoue T, Nishida E . Molecular recognitions in the MAP kinase cascades. Cell Signal. 2003; 15(5):455-62. DOI: 10.1016/s0898-6568(02)00112-2. View

13.

Yang T, Suk H, Yang X, Olabisi O, Yu R, Durand J . Role of transcription factor NFAT in glucose and insulin homeostasis. Mol Cell Biol. 2006; 26(20):7372-87. PMC: 1636854. DOI: 10.1128/MCB.00580-06. View

14.

Buschbeck M, Ullrich A . The unique C-terminal tail of the mitogen-activated protein kinase ERK5 regulates its activation and nuclear shuttling. J Biol Chem. 2004; 280(4):2659-67. DOI: 10.1074/jbc.M412599200. View

15.

Reiling J, Sabatini D . Stress and mTORture signaling. Oncogene. 2006; 25(48):6373-83. DOI: 10.1038/sj.onc.1209889. View

16.

Ranganathan A, Pearson G, Chrestensen C, Sturgill T, Cobb M . The MAP kinase ERK5 binds to and phosphorylates p90 RSK. Arch Biochem Biophys. 2006; 449(1-2):8-16. DOI: 10.1016/j.abb.2006.02.023. View

17.

Buhaescu I, Izzedine H, Covic A . Sirolimus--challenging current perspectives. Ther Drug Monit. 2006; 28(5):577-84. DOI: 10.1097/01.ftd.0000245377.93401.39. View

18.

Zhu J, Shibasaki F, Price R, Guillemot J, Yano T, Dotsch V . Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell. 1998; 93(5):851-61. DOI: 10.1016/s0092-8674(00)81445-2. View

19.

Cameron S, Malik S, Akaike M, Lerner-Marmarosh N, Yan C, Lee J . Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation. J Biol Chem. 2003; 278(20):18682-8. DOI: 10.1074/jbc.M213283200. View

20.

Beals C, Sheridan C, Turck C, Gardner P, Crabtree G . Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science. 1997; 275(5308):1930-4. DOI: 10.1126/science.275.5308.1930. View